vs
Grocery Outlet Holding Corp.（GO）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是Grocery Outlet Holding Corp.的1.2倍（$1.4B vs $1.2B），瑞思迈净利率更高（27.6% vs -18.5%，领先46.1%），瑞思迈同比增速更快（11.0% vs 10.7%），过去两年瑞思迈的营收复合增速更高（9.0% vs 8.3%）
Grocery Outlet Holding Corp.是美国知名的折扣清仓零售企业，旗下所有门店均为超市，主打销售品牌厂商及自有品牌供应商的库存积压与清仓商品，价格优惠。目前该公司的门店已分布在美国加利福尼亚、俄勒冈、华盛顿、爱达荷等十余州。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
GO vs RMD — 直观对比
营收规模更大
RMD
是对方的1.2倍
$1.2B
营收增速更快
RMD
高出0.3%
10.7%
净利率更高
RMD
高出46.1%
-18.5%
两年增速更快
RMD
近两年复合增速
8.3%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $1.4B |
| 净利润 | $-224.9M | $392.6M |
| 毛利率 | 29.7% | 61.8% |
| 营业利润率 | — | 34.6% |
| 净利率 | -18.5% | 27.6% |
| 营收同比 | 10.7% | 11.0% |
| 净利润同比 | -669.9% | 13.9% |
| 每股收益（稀释后） | $-2.22 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GORMD
| Q1 26 | $1.2B | — | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.1B | $1.3B | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $1.1B | $1.2B |
净利润GORMD
| Q1 26 | $-224.9M | — | ||
| Q4 25 | — | $392.6M | ||
| Q3 25 | $11.6M | $348.5M | ||
| Q2 25 | $5.0M | $379.7M | ||
| Q1 25 | $-23.3M | $365.0M | ||
| Q4 24 | $2.3M | $344.6M | ||
| Q3 24 | $24.2M | $311.4M | ||
| Q2 24 | $14.0M | $292.2M |
毛利率GORMD
| Q1 26 | 29.7% | — | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | 30.4% | 61.5% | ||
| Q2 25 | 30.6% | 60.8% | ||
| Q1 25 | 30.4% | 59.3% | ||
| Q4 24 | 29.5% | 58.6% | ||
| Q3 24 | 31.1% | 58.6% | ||
| Q2 24 | 30.9% | 58.5% |
营业利润率GORMD
| Q1 26 | — | — | ||
| Q4 25 | — | 34.6% | ||
| Q3 25 | 2.0% | 33.4% | ||
| Q2 25 | 1.1% | 33.7% | ||
| Q1 25 | -2.0% | 33.0% | ||
| Q4 24 | 1.0% | 32.5% | ||
| Q3 24 | 3.6% | 31.6% | ||
| Q2 24 | 2.3% | 31.2% |
净利率GORMD
| Q1 26 | -18.5% | — | ||
| Q4 25 | — | 27.6% | ||
| Q3 25 | 1.0% | 26.1% | ||
| Q2 25 | 0.4% | 28.2% | ||
| Q1 25 | -2.1% | 28.3% | ||
| Q4 24 | 0.2% | 26.9% | ||
| Q3 24 | 2.2% | 25.4% | ||
| Q2 24 | 1.2% | 23.9% |
每股收益（稀释后）GORMD
| Q1 26 | $-2.22 | — | ||
| Q4 25 | — | $2.68 | ||
| Q3 25 | $0.12 | $2.37 | ||
| Q2 25 | $0.05 | $2.58 | ||
| Q1 25 | $-0.24 | $2.48 | ||
| Q4 24 | $0.03 | $2.34 | ||
| Q3 24 | $0.24 | $2.11 | ||
| Q2 24 | $0.14 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.6M | $1.4B |
| 总债务越低越好 | $15.0M | $403.9M |
| 股东权益账面价值 | $983.7M | $6.3B |
| 总资产 | $3.1B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.02× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资GORMD
| Q1 26 | $69.6M | — | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $52.1M | $1.4B | ||
| Q2 25 | $55.2M | $1.2B | ||
| Q1 25 | $50.9M | $932.7M | ||
| Q4 24 | $62.8M | $521.9M | ||
| Q3 24 | $68.7M | $426.4M | ||
| Q2 24 | $67.1M | $238.4M |
总债务GORMD
| Q1 26 | $15.0M | — | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | $500.3M | $408.7M | ||
| Q2 25 | $473.9M | $658.4M | ||
| Q1 25 | $475.7M | $663.1M | ||
| Q4 24 | $477.5M | $662.9M | ||
| Q3 24 | $429.3M | $667.6M | ||
| Q2 24 | $379.2M | $697.3M |
股东权益GORMD
| Q1 26 | $983.7M | — | ||
| Q4 25 | — | $6.3B | ||
| Q3 25 | $1.2B | $6.1B | ||
| Q2 25 | $1.2B | $6.0B | ||
| Q1 25 | $1.2B | $5.5B | ||
| Q4 24 | $1.2B | $5.3B | ||
| Q3 24 | $1.2B | $5.2B | ||
| Q2 24 | $1.2B | $4.9B |
总资产GORMD
| Q1 26 | $3.1B | — | ||
| Q4 25 | — | $8.5B | ||
| Q3 25 | $3.4B | $8.3B | ||
| Q2 25 | $3.3B | $8.2B | ||
| Q1 25 | $3.3B | $7.6B | ||
| Q4 24 | $3.2B | $7.1B | ||
| Q3 24 | $3.1B | $7.2B | ||
| Q2 24 | $3.1B | $6.9B |
负债/权益比GORMD
| Q1 26 | 0.02× | — | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | 0.42× | 0.07× | ||
| Q2 25 | 0.40× | 0.11× | ||
| Q1 25 | 0.40× | 0.12× | ||
| Q4 24 | 0.40× | 0.13× | ||
| Q3 24 | 0.35× | 0.13× | ||
| Q2 24 | 0.31× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $222.1M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | — | $311.2M |
| 自由现金流率自由现金流/营收 | — | 21.9% |
| 资本支出强度资本支出/营收 | — | 2.0% |
| 现金转化率经营现金流/净利润 | — | 0.87× |
| 过去12个月自由现金流最近4个季度 | — | $1.8B |
8季度趋势，按日历期对齐
经营现金流GORMD
| Q1 26 | $222.1M | — | ||
| Q4 25 | — | $339.7M | ||
| Q3 25 | $17.3M | $457.3M | ||
| Q2 25 | $73.6M | $538.8M | ||
| Q1 25 | $58.9M | $578.7M | ||
| Q4 24 | $39.5M | $308.6M | ||
| Q3 24 | $23.0M | $325.5M | ||
| Q2 24 | $41.6M | $440.1M |
自由现金流GORMD
| Q1 26 | — | — | ||
| Q4 25 | — | $311.2M | ||
| Q3 25 | $-21.6M | $414.4M | ||
| Q2 25 | $14.4M | $508.2M | ||
| Q1 25 | $-1.5M | $557.9M | ||
| Q4 24 | $-19.6M | $288.0M | ||
| Q3 24 | $-19.3M | $307.7M | ||
| Q2 24 | $2.7M | $415.2M |
自由现金流率GORMD
| Q1 26 | — | — | ||
| Q4 25 | — | 21.9% | ||
| Q3 25 | -1.8% | 31.0% | ||
| Q2 25 | 1.2% | 37.7% | ||
| Q1 25 | -0.1% | 43.2% | ||
| Q4 24 | -1.8% | 22.5% | ||
| Q3 24 | -1.7% | 25.1% | ||
| Q2 24 | 0.2% | 33.9% |
资本支出强度GORMD
| Q1 26 | — | — | ||
| Q4 25 | — | 2.0% | ||
| Q3 25 | 3.3% | 3.2% | ||
| Q2 25 | 5.0% | 2.3% | ||
| Q1 25 | 5.4% | 1.6% | ||
| Q4 24 | 5.4% | 1.6% | ||
| Q3 24 | 3.8% | 1.5% | ||
| Q2 24 | 3.4% | 2.0% |
现金转化率GORMD
| Q1 26 | — | — | ||
| Q4 25 | — | 0.87× | ||
| Q3 25 | 1.49× | 1.31× | ||
| Q2 25 | 14.84× | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | 17.09× | 0.90× | ||
| Q3 24 | 0.95× | 1.05× | ||
| Q2 24 | 2.97× | 1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GO
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
